Finance

Lists
4967:TYO
Kobayashi Pharmaceutical Co Ltd
Â¥6,945.00
+1.40%
(+96.00) 1D
Sep 30, 3:30:00 PM GMT+9  ·   JPY
All symbols
SymbolPriceChange% Change
Generating top insights for 4967...
Open
Â¥6,849
High
Â¥6,945
Low
Â¥6,808
Mkt. cap
542.06B
Avg. vol.
260.96K
Volume
459.90K
Dividend
1.51%
Quarterly dividend
Â¥26
Ex-dividend date
Dec 29, 2026
P/E ratio
317.71
52-wk high
Â¥7,169
52-wk low
Â¥5,030
EPS
Â¥22
Shares outstanding
79.07M
No. of employees
4K
Open
Â¥6,849
High
Â¥6,945
Low
Â¥6,808
Mkt. cap
542.06B
Avg. vol.
260.96K
Volume
459.90K
Dividend
1.51%
Quarterly dividend
Â¥26
Ex-dividend date
Dec 29, 2026
P/E ratio
317.71
52-wk high
Â¥7,169
52-wk low
Â¥5,030
EPS
Â¥22
Shares outstanding
79.07M
No. of employees
4K
About Kobayashi Pharmaceutical Co Ltd
CEOKazumasa Kobayashi
Employees3.73K
FoundedAug 22, 1919
Headquarters-
SectorPersonal care products
Websitekobayashi.co.jp
Last report
Aug 6, 2026
Fiscal period
Q2 2026
EPS / Est. (JPY)
- / -
Revenue / Est. (JPY)
37.08B / 37.51B
Fiscal Q2 2026 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in JPY
Loading Previous Earnings...
Revenue
Net income
All values in JPY
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Revenue
43.02B
53.70B
35.38B
37.08B
Cost of goods sold
20.30B
27.85B
17.21B
18.19B
Cost of revenue
20.30B
27.85B
17.21B
18.19B
Research and development expenses
-
9.12B
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
17.87B
6.76B
17.10B
18.08B
Operating expense
17.87B
22.50B
17.10B
18.04B
Total operating expenses
38.17B
50.36B
34.31B
36.23B
Operating income
4.85B
3.35B
1.06B
851.00M
Other non operating income
593.00M
-150.00M
-530.00M
20.00M
EBT including unusual items
5.02B
-5.52B
1.11B
483.00M
EBT excluding unusual items
5.68B
4.07B
829.50M
1.33B
Income tax expense
1.37B
-2.37B
541.00M
383.00M
Effective tax rate
27.33%
42.97%
48.76%
79.30%
Other operating expenses
-
1.26B
-
-
Net income
3.64B
-3.15B
568.00M
100.00M
Net profit margin
8.47%
-5.87%
1.61%
0.27%
Earnings per share
-
-
-
-
Interest and investment income
94.00M
448.00M
295.50M
454.00M
Interest expense
-3.00M
-13.00M
-5.00M
-6.00M
Net interest expenses
91.00M
435.00M
290.50M
448.00M
Depreciation and amortization charges
-
3.89B
-
-
EBITDA
6.85B
5.53B
3.45B
3.24B
Gain or loss from assets sale
-
-
39.50M
-
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google apps